An activated near-infrared fluorescence / photoacoustic dual-mode in vivo imaging probe for detecting sulfatase, and its preparation method and application
By developing the activated near-infrared fluorescence/photoacoustic dual-modal imaging probe Hcy-SA, the problem of low detection sensitivity of existing probes in living bodies is solved, and high sensitivity detection of sulfate esterase activity and tumor cell distinction is achieved. , provides tools for sulfate esterase-related pathological research and cancer diagnosis.
Patent Information
- Application Number
- CN202310440587.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-23
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-04-23
AI Technical Summary
The existing sulfate esterase-activated probes have short absorption/emission wavelengths, resulting in excessive autofluorescence, limited penetration depth and low sensitivity, which limit their detection application in living biological systems.
An activated near-infrared fluorescence/photoacoustic dual-modal imaging probe Hcy-SA was developed. This probe is converted into dye Hcy-OH by specific hydrolysis of sulfate esterase, activates near-infrared fluorescence/photoacoustic signals, and realizes the Detection of sulfate esterase activity. This probe has the advantages of good water solubility, strong biocompatible, fast response speed, high sensitivity and strong specificity.
It realizes high sensitivity detection of sulfate esterase activity, can distinguish tumor cells from normal cells in living body, and has high contrast and spatial resolution, providing tools for sulfate esterase-related pathological research and cancer diagnosis.
Smart Images

Figure CN116514787B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of imaging probe detection, and particularly relates to an activated near-infrared fluorescence / photoacoustic dual-mode in vivo imaging probe for detecting sulfatase, and a preparation method and application thereof. Background Art
[0002] Sulfatases are a class of enzymes that play a catabolic role by catalyzing the hydrolysis of sulfate bonds in sulfate substrates of various biomolecules. Sulfatases are involved in various biological processes, such as degradation of macromolecules, cell signaling, hormone regulation, and bacterial pathogenesis. Currently, 17 genes of the sulfatase superfamily have been identified, and abnormal levels of each sulfatase subtype are closely related to the occurrence and development of many diseases, such as multiple sulfatase deficiency syndrome and cancer. For example, overexpression of heparan sulfate sulfatase (Sulf-2) promotes the occurrence of human lung cancer and is also upregulated in hepatocellular carcinoma. In addition, upregulation of steroid sulfatase (STS) levels leads to increased hormone production, resulting in the occurrence of hormone-dependent cancers, especially breast cancer. Currently, STS inhibitors such as STX64 and EMATE have been used in the clinical treatment of breast cancer. Therefore, accurate quantification of sulfatase activity under physiological conditions is of great significance for the diagnosis and treatment of sulfatase-related diseases.
[0003] Fluorescent probes combined with imaging technology have high sensitivity, high spatiotemporal resolution, and non-destructive rapid analysis capabilities in enzyme activity detection. In particular, activated fluorescent probes can generate enhanced fluorescence signals when interacting with enzymes, thereby achieving high contrast response and high sensitivity detection of enzymes. However, the current sulfatase activated probes have excessive autofluorescence, limited penetration depth, and limited sensitivity due to their short absorption / emission wavelengths, which limits their application in the detection of sulfatase in living biological systems. Therefore, there is still a lack of highly sensitive methods for detecting sulfatase activity in living biological systems. Summary of the invention
[0004] In view of the shortcomings of the prior art, the present invention provides an activation-type near-infrared fluorescence / photoacoustic (NIRF / PA) dual-modal imaging probe (Hcy-SA) that responds to sulfatase in living bodies; the probe Hcy-SA can be converted into a dye Hcy-OH by sulfatase-specific hydrolysis, thereby activating the NIRF / PA signal and realizing the detection of sulfatase activity. The probe has the advantages of good water solubility, strong biocompatibility, fast response speed, high sensitivity and strong specificity when detecting sulfatase activity in vitro. At the same time, a preparation method of the probe is provided, and a synthesis method of Hcy-SA and its application in living bodies are further provided. The probe Hcy-SA can also distinguish tumor cells from normal cells based on the activity of sulfatase. Therefore, the probe can provide a promising tool for sulfatase-related pathological research and cancer diagnosis.
[0005] The technical solution of the present invention is as follows:
[0006] An activated near-infrared fluorescence / photoacoustic dual-mode in vivo imaging probe for detecting sulfatase, the dual-mode in vivo imaging probe is named Hcy-SA, and its chemical structure is shown in Formula I;
[0007]
[0008] Formula Ⅰ.
[0009] Preferably, the dual-mode in vivo imaging probe can be used for quantitative detection in vitro; and / or can distinguish tumor cells from normal cells; and / or can be localized to lysosomes; and / or can achieve near-infrared fluorescence and photoacoustic dual-mode imaging of sulfatases in tumors of living animals.
[0010] Another object of the present invention is to protect the preparation method of the above-mentioned dual-mode in vivo imaging probe, which comprises the following steps: mixing pyridine sulfur trioxide, hemicyanine dye Hcy-OH, sodium ethoxide and N,N-dimethylformamide, and stirring the reaction; vacuum concentrating, using dichloromethane, methanol, and acetic acid as eluents, and purifying the obtained residue by column chromatography to obtain a blue-green solid product, named Hcy-SA.
[0011] Furthermore, the preparation method of the hemicyanine-like dye Hcy-OH is: slowly adding triethylamine to a DMF solution of 4-chlororesorcinol and stirring; then adding the compound CySO 3 Cl in DMF solution, stirred; after purification, Hcy-OH is obtained; its chemical structure is shown in Formula II:
[0012]
[0013] Formula II.
[0014] Furthermore, the molar ratio of the hemicyanine-like dye Hcy-OH to pyridine sulfur trioxide is 3:5.
[0015] Furthermore, the stirring reaction time is more than 12 hours and the temperature is 50°C.
[0016] Furthermore, the eluent is dichloromethane, methanol and acetic acid in a volume ratio of 8:1:0.1.
[0017] Another object of the present invention is to protect the application of the above-mentioned dual-mode in vivo imaging probe, characterized in that it monitors the activity of sulfatase in lysosomes.
[0018] The Turn-on NIRF / PA dual-mode imaging probe of the present invention is composed of a sulfate part as a recognition unit and a semi-cyanine dye (Hcy-OH) as a NIRF / PA signal group. After reacting with sulfatase, the sulfate part of the probe Hcy-SA is specifically cleaved and removed, resulting in the release of Hcy-OH, thereby activating NIRF and PA signals, and then responding to the activity of sulfatase. The absorption wavelength of the probe after response is relatively long (680 nm), the fluorescence emission wavelength is in the near-infrared region (712 nm), and the maximum photoacoustic intensity is at 700 nm. The probe not only has less background interference, but also has stronger tissue penetration and higher spatial resolution, so that the dual-mode imaging probe of the present invention has a high-contrast NIRF / PA imaging effect for sulfatase in cells and living bodies. As far as we know, this is the first NIRF / PA dual-mode probe that can be used to monitor sulfatase activity in living cells and mouse tumor models. Because its long wavelength is in the near-infrared part, it is less harmful to living organisms. Overall, this activatable NIRF / PA dual-mode probe will provide a powerful tool for sulfatase-related pathological studies and disease diagnosis.
[0019] Beneficial effects of the present invention:
[0020] (1) The introduction of sulfonic acid groups into the structure makes the probe have good water solubility. There is no need to introduce organic reagents for dissolution, which will not damage the activity of the enzyme and enhance biocompatibility. The probe is transparent sky blue in water and can directly respond to sulfatase in aqueous solution. After the response, the color changes to transparent lake green. The color change before and after is obvious and can be detected by naked eyes, which is convenient and fast.
[0021] (2) Rapid and sensitive response, low detection limit
[0022] The activated NIRF / PA dual-mode imaging probe responds rapidly to sulfatase within 3 minutes. When responding to sulfatase, the in vitro fluorescence intensity and photoacoustic intensity increase by 8.3 times and 7.3 times, respectively. The detection limits of fluorescence and photoacoustic are 0.23 U / L and 0.3 U / L, respectively.
[0023] (3) Specific monitoring of sulfatase activity in lysosomes of tumor cells
[0024] The activated NIRF / PA dual-mode imaging probe of the present invention can distinguish tumor cells from normal cells by flow cytometry; can specifically monitor the activity of sulfatase in lysosomes; has low cytotoxicity and good biocompatibility, and can realize NIRF / PA dual-mode imaging of sulfatase at the cellular and in vivo levels. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1It is the hemicyanine dye Hcy-OH in dimethyl sulfoxide-d6 (DMSO-d6) 1 H NMR spectrum;
[0026] Figure 2 For CD 3 The hemicyanine dye Hcy-OH in OD 13 C NMR spectrum;
[0027] Figure 3 This is the ESI-MS spectrum of the hemicyanine-like dye Hcy-OH;
[0028] Figure 4 is the probe Hcy-SA of the present invention in dimethyl sulfoxide-d6 (DMSO-d6) 1 H NMR spectrum;
[0029] Figure 5 Dimethyl sulfoxide-d6 (DMSO- d 6 ) in which the probe Hcy-SA of the present invention 13 C NMR spectrum;
[0030] Figure 6 This is the ESI-MS spectrum of the probe Hcy-SA of the present invention;
[0031] Figure 7 The color change diagram of the Hcy-SA aqueous solution (100 μM) of the probe of the present invention before and after the reaction with sulfatase (50 U / L) (A) and the UV-visible absorption spectrum diagram of the solution after being diluted 5 times (B);
[0032] Figure 8 The time-dependent NIRF712 intensity of the probe Hcy-SA (10 μM) of the present invention in the presence or absence of sulfatase (20 U / L). Ex / Em: 680nm / 712nm. Error bars represent the standard deviation of three separate measurements;
[0033] Fig. 9 The NIRF spectra (A), the NIRF712 intensity and enzyme concentration fitting curve (B), the PA image (C) and the PA700 intensity and enzyme concentration fitting curve (D) of the probe Hcy-SA (10 μM) of the present invention and different concentrations of sulfatase (0-30 U / L) in pH 7.0 Tris-HCl solution at 37°C for 10 min.
[0034] Fig.10 NIRF (A) and PA (B) selectivity plots for the probe Hcy-SA (10 μM) of the present invention in detecting sulfatase; error bars represent the standard deviation of three separate measurements;
[0035] Fig.11 To evaluate the cytotoxicity of the probe Hcy-SA content of the present invention on different cells;
[0036] Fig.12 NIRF (A) and PA (B) images of the probe Hcy-SA of the present invention in MCF-7 cells; control group (a), incubated with Hcy SA (50 μM) for 3 hours in the absence of STX-64 (b) or in the presence of STX-64 (c). Scale bar = 10 μm;
[0037] Fig.13 Figure 1 is the flow cytometry analysis of different cells;
[0038] Fig.14 This is the organelle co-localization diagram of the probe Hcy-SA of the present invention in the fluorescence imaging of MCF-7 cells; MCF-7 cells were incubated with Hcy-SA (50 μM) for 3 hours and then incubated with 100 nM Lyso-Tracker Green (or Mito-Tracker Green) for 30 minutes; scale bar = 10 μm;
[0039] Fig.15 NIRF imaging of the probe Hcy-SA of the present invention on the sulfatase activity in MCF-7 cell tumor-bearing mice; (A) Representative NIRF images of MCF-7 tumor-bearing nude mice at different time points after intratumoral injection of Hcy-SA (200 μM, 50 μL); the dotted line indicates the tumor area; (B) Time-dependent NIRF intensity changes of MCF-7 tumor-bearing mice (n=3) treated under the conditions described in (A); (C) Representative in vivo NIRF images of nude mice injected with PBS (a), Hcy-SA alone (b), or STX-64 followed by Hcy-SA (c) intratumorally; the dotted line indicates the tumor area; (D) Corresponding NIRF intensity of images of nude mice (n=3) treated under the conditions described in (C); the error bars indicate the standard deviation of three separate measurements;
[0040] Fig.16The PA imaging diagram of the probe Hcy-SA of the present invention on the sulfatase activity in vivo in mice bearing MCF-7 cells. (A) Representative images of PA imaging of MCF-7 tumor-bearing nude mice at different time points after intratumoral injection of Hcy-SA (200 μM, 50 μL); the dotted line indicates the tumor area; (B) Time-dependent PA intensity changes of MCF-7 tumor-bearing mice (n=3) treated under the conditions described in (A); (C) Representative images of in vivo PA imaging of nude mice injected with PBS (a), Hcy SA alone (b), or STX-64 followed by HcySA (c) intratumorally; (D) Corresponding PA intensity of images of nude mice (n=3) treated under the conditions described in (C); the error bars indicate the standard deviation of three separate measurements;
[0041] Fig.17 NIRF imaging diagrams of the organ distribution of the probe Hcy-SA of the present invention in vivo; (A) Representative images of ex vivo NIRF imaging of major organs (heart, liver, spleen, lung and kidney) and tumors dissected from MCF-7 tumor-bearing mice 18 hours after injection of Hcy-SA; (B) NIRF intensity of major organs and tumors of MCF-7 tumor-bearing mice 18 hours after tail vein injection of Hcy-SA as shown in (A); error bars represent the standard deviation of three separate measurements. DETAILED DESCRIPTION
[0042] The following description further describes the specific details of the present invention for a full understanding of the present invention. The terms used in the description of the present invention are only used to illustrate the advantages and features of the present invention and are not intended to limit the present invention.
[0043] Unless otherwise defined, all professional and scientific terms used in the present invention have the same meanings as those understood by technicians in the technical field of the present invention. Unless otherwise specified, the drugs or reagents used in the present invention are used in accordance with the product instructions or the conventional methods of use in the field. The method is now further described based on the drawings and specific implementation methods of the specification.
[0044] Example 1
[0045] Preparation process of hemicyanine dye Hcy-OH, refer to route 1,
[0046]
[0047] Route 1
[0048] The specific steps are as follows:
[0049] Triethylamine (TEA, 0.41 mL, 3 mmol) was slowly added to a mixture of 4-chlororesorcinol (0.44 g, 3 mmol) and DMF (5 mL), and the solution was stirred at room temperature for 1 h. Compound CySO was then added. 3 Cl (1.4 g, 2 mmol) in DMF (5 mL) was added and the mixed solution was stirred at 80 °C for 4 h. The solvent was removed by rotary evaporation and the residue was purified by column chromatography using DCM / MeOH (15 / 1, v / v) as the eluent. The green solid was Hcy-OH with a yield of 43%.
[0050] The semi-cyanine dye Hcy-OH prepared in this example was tested, and the results were as follows: Figures 1 to 3 As shown, they are: Figure 1 It is the hemicyanine dye Hcy-OH in dimethyl sulfoxide-d6 (DMSO-d6) 1 H NMR spectrum; Figure 2 For CD 3 Hcy-OH in OD 13 C NMR spectrum; Figure 3 This is the ESI-MS spectrum of the hemicyanine-like dye Hcy-OH.
[0051] in, Figure 1 The hydrogen spectrum of is analyzed as follows: 1 H NMR (400 MHz, DMSO- d 6 ) δ (ppm): 8.38 (1H, d, J =14.4 Hz, Ar-H), 7.65-7.68 (2H, m, Ar-H), 7.59 (1H, d, J = 8.0 Hz, Ar-H), 7.47(1H, s, Ar-H), 7.31-7.44 (2H, m, 2 × CH=), 6.83 (1H, s, Ar-H), 6.57 (1H, d, J = 14.0 Hz, CH=), 4.43 (2H, t, J = 6.8 Hz, CH 2 ), 2.65-2.73 (4H, m, 2 × CH 2 ),2.59 (2H, t, J = 6.8 Hz, CH 2 ), 1.98-2.09 (2H, m, CH 2 ), 1.81 (2H, t, J= 5.6 Hz,CH 2 ), 1.72 (6H, s, 2 × CH 3 ).
[0052] Figure 2 The carbon spectrum of is: 13 C NMR (100 MHz, CD 3 OD) δ (ppm): 173.37, 170.48,162.32, 158.66, 150.18, 147.32, 143.44, 141.62, 140.98, 130.79, 129.39,128.52, 127.35, 124.67, 122.45, 115.74, 114.92, 113.30, 111.26, 109.43,51.21, 49.77, 42.85, 28.18, 27.19, 20.44, 20.01, 9.28.
[0053] Figure 3 The ESI-MS mass spectrum analysis (negative ion mode in water) is: the theoretical molecular weight of Hcy-OH is 524.13; the actual detection: the molecular weight is 524.20.
[0054] The above results prove that the present embodiment has successfully synthesized a hemicyanine-like dye Hcy-OH, whose structural formula is:
[0055]
[0056] Example 2 Preparation process of dual-mode imaging probe Hcy-SA, refer to route 2,
[0057]
[0058] Route 2
[0059] The specific steps are as follows:
[0060] Pyridine sulfur trioxide (0.048 g, 0.3 mmol) was added to the hemicyanine dye Hcy-OH (0.053 g, 0.1 mmol), sodium ethoxide (CH 3 CH 2 ONa, 0.034 g, 0.5 mmol) and N,N-dimethylformamide (DMF, 5 mL) and stirred at 50 °C overnight. After vacuum concentration, the mixture was heated to 40 ℃ and then heated to 30 ℃ with dichloromethane / methanol / acetic acid (DCM / MeOH / CH 3The residue was purified by column chromatography using 4% paraformaldehyde (2-nitropropene) and 1% paraformaldehyde (2-nitropropene) as the eluent to afford the product as a blue-green solid, named Hcy-SA, in a yield of 51%.
[0061] The probe Hcy-SA prepared in this example was tested, and the results were as follows: Figures 4 to 6 As shown, they are: Figure 4 For the probe Hcy-SA in dimethyl sulfoxide-d6 (DMSO-d6) 1 H NMR spectrum; Figure 5 Dimethyl sulfoxide-d6 (DMSO- d 6 ) 13 C NMR spectrum; Figure 6 This is the ESI-MS spectrum of the probe Hcy-SA.
[0062] in, Figure 4 The hydrogen spectrum of is analyzed as follows: 1 H NMR (400 MHz, DMSO- d 6 ) δ (ppm): 8.56 (1H, d, J =15.2 Hz, Ar-H), 7.87 (1H, d, J = 7.6 Hz, Ar-H), 7.78-7.82 (2H, m, Ar-H), 7.64(1H, s, Ar-H), 7.51-7.61 (2H, m, 2 × CH=), 7.29 (1H, s, Ar-H), 6.97 (1H, d, J = 15.2 Hz, CH=), 4.68 (2H, t, J = 7.6 Hz, CH 2 ), 2.71-2.75 (4H, m, 2 × CH 2 ),2.62 (2H, t, J = 6.4 Hz, CH 2 ), 2.08-2.15 (2H, m, CH 2 ), 1.83 (2H, t, J = 6.0 Hz,CH 2 ), 1.77 (6H, s, 2 × CH 3 ).
[0063] Figure 5 The carbon spectrum of is: 13C NMR (100 MHz, DMSO-d6) δ (ppm): 169.70, 168.66,158.25, 151.58, 148.29, 146.11, 142.81, 141.61, 131.64, 129.39, 128.36,127.89, 123.27, 122.59, 121.36, 115.58, 114.48, 112.57, 108.10, 51.42, 47.84,46.00, 27.63, 20.68, 19.07, 13.93, 9.13.
[0064] Figure 6 The ESI-MS mass spectrometry analysis (negative ion mode in water) is: the theoretical molecular weight of Hcy-SA is 604.09; the actual detection: the molecular weight is 604.10.
[0065] The above results prove that the probe Hcy-SA has been successfully synthesized in this example, and its structural formula is:
[0066]
[0067] Example 3 Analysis of the performance of the dual-mode imaging probe Hcy-SA in detecting sulfatase in vitro:
[0068] (1) Investigating the solubility of the prepared probe Hcy-SA and its color change in response to sulfatase
[0069] In order to study the solubility of the probe Hcy-SA and its color change reaction to sulfatase, two portions of Hcy-SA were dissolved in 200 uL of water to a final concentration of (100 μM), one portion was left untreated, and the other portion was reacted with sulfatase (20 U / L) in 37°C water for 10 minutes. Then the color change was photographed with a mobile phone, and the results are shown in Figure 7 As shown in A. The probe is transparent sky blue in water, indicating good water solubility. Moreover, the probe can directly respond to sulfatase in aqueous solution, and the color changes to transparent lake green after the response. The color change before and after is obvious, which can be detected by naked eyes, which is convenient and fast.
[0070] The above solutions were diluted 5 times and their UV-visible spectra were measured. The results are as follows: Figure 7 As shown in Figure B, it can be found that after the probe is incubated with sulfatase, the absorption peaks of the probe Hcy-SA at 556nm and 591nm disappear, and a new absorption peak appears at 685nm. This change also proves that Hcy-SA can produce a significant response to sulfatase.
[0071] (2) Investigate the ability of the prepared probe Hcy-SA to respond to sulfatase in real-time fluorescence:
[0072] To study the reaction kinetics of the probe Hcy-SA to sulfatase, Hcy-SA (10 μM) was quickly mixed with different concentrations of sulfatase (0 and 20 U / L) in Tris-HCl buffer (10 mM, pH 7.0). Then, the fluorescence intensity at 712 nm was recorded at different times (0, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0 min) within 10 min on an Edinburgh FLS1000stm fluorescence spectrophotometer with an excitation wavelength of 680 nm. The results are shown in Figure 8 shown.
[0073] from Figure 8 It can be seen that the fluorescence of the probe Hcy-SA is very weak when the sulfatase is not present and the fluorescence intensity remains unchanged as time increases. However, the fluorescence of the probe Hcy-SA with the addition of sulfatase gradually increases as time increases, and the response to the sulfatase is very rapid, reaching a platform within 3 minutes. The above results show that the prepared probe responds quickly to the sulfatase.
[0074] (3) Investigate the ability of the prepared probe Hcy-SA to quantitatively detect sulfatase in vitro:
[0075] To investigate the ability of Hcy-SA to quantify sulfatase activity, the probe Hcy-SA (10 μM) was mixed with different concentrations of sulfatase (0-30 U / L) in Tris-HCl buffer (10 mM, pH 7.0) and incubated at 37°C for 10 min. Under 680 nm excitation, the fluorescence emission spectrum of the prepared probe for detecting sulfatase was obtained with the near-infrared fluorescence (NIRF) emission wavelength of 712 nm as the abscissa and the NIRF intensity as the ordinate. The results are shown in Figure 2. Fig. 9 As shown in A. With the concentration of sulfatase as the horizontal axis and the corresponding NIRF intensity at 712 nm as the vertical axis, the fluorescence linear spectrum of the probe Hcy-SA detecting sulfatase was obtained. The results are shown in Fig. 9 As shown in B.
[0076] In addition, we also recorded the photoacoustic (PA) intensity at 700 nm (PA700 intensity) of Hcy-SA treated with different concentrations of sulfatase (0-20U / L) to verify the feasibility of quantitative analysis of sulfatase by Hcy-SA through PA mode. For in vitro photoacoustic (PA) detection, wells (200μL) filled with Hcy-SA and analytes were subjected to PA imaging with the MSOT imaging system, scanning from 680nm to 850nm at intervals of 10nm. Wells filled with PBS were used as controls for background inference. All MSOT data were acquired with the MSOT imaging system with the following parameters: pulse frequency (10Hz), pulse length (8ns), and maximum optical parameter oscillator energy (120mJ at 740nm). Light was delivered to the sample through a ring-shaped fiber bundle. The resulting acoustic signal was collected using a 256-element transducer array. The resulting photoacoustic images and results are shown in Fig. 9 C. With the concentration of sulfatase as the horizontal axis and the corresponding PA intensity at 700 nm as the vertical axis, the PA linear spectrum of the probe Hcy-SA detecting sulfatase was obtained. The results are shown in Fig. 9 As shown in D.
[0077] from Fig. 9 A shows that after adding sulfatase, the probe Hcy-SA can show an obvious fluorescence emission peak at 712nm under the excitation of 680nm, and its fluorescence emission peak is significantly enhanced with the increase of sulfatase concentration, indicating that the probe Hcy-SA can react significantly with sulfatase. Fig. 9 B shows that within the sulfatase concentration range of 0.3-12 U / L, the NIRF fluorescence intensity of the probe Hcy-SA shows good linearity with the sulfatase concentration, and the detection limit for sulfatase is 0.23 U / L. Fig. 9 C and Fig. 9 As can be seen in D, the PA700 intensity of the dual-mode imaging probe Hcy-SA of the present invention increases with the increase of sulfatase concentration, and increases proportionally in the range of 0.5-10U / L. The detection limit of the PA mode is as low as 0.3U / L, which is basically consistent with the result of NIRF mode measurement. In summary, the probe Hcy-SA can realize NIRF / PA dual-mode quantitative detection of sulfatase in vitro.
[0078] (4) Investigating the response specificity of the prepared probe Hcy-SA to sulfatase
[0079] To explore the selectivity of the probe Hcy-SA, Hcy-SA was first mixed with different biomolecules, including nitro reductase (100 U / L), α-glucosidase (100 U / L), alkaline phosphatase (100 U / L), glucose oxidase (100 U / L), acetylcholinesterase (100 U / L), catalase (100 U / L), bovine serum albumin (0.1 mg / mL), tyrosinase (100u / L), horse radish peroxidase (100U / L), glutathione (1mM), and sulfatase (50 U / L). The mixture was then incubated in Tris-HCl buffer (10 mM, pH 7.0) at 37°C for 10 min, and the fluorescence spectrum was obtained on an Edinburgh FLS1000 stm fluorescence spectrophotometer. The fluorescence selectivity spectrum of the prepared probe Hcy-SA for detecting sulfatase was obtained with different targets as the abscissa and the corresponding NIRF intensity at 712 nm as the ordinate. The results are shown in Figure 2. Fig.10 A. With different targets as the horizontal axis and the corresponding PA intensity at 700 nm as the vertical axis, the photoacoustic selectivity map of the probe for detecting sulfatase was obtained. The results are shown in Fig.10 As shown in B.
[0080] from Fig.10 As can be seen from A, when Hcy-SA was incubated with other interfering biomolecules, no significant increase in NIRF intensity was observed at 712 nm, but only when it was incubated with sulfatase, a significant NIRF enhancement was observed, indicating a high specific response of the probe to sulfatase. Fig.10 B shows that in the presence of sulfatase, the highest PA intensity at 700 nm was also obtained, which is basically consistent with the fluorescence measurement results. The above results show that the prepared probe Hcy-SA can achieve highly specific NIRF / PA detection of sulfatase.
[0081] Example 4 investigates the performance of the prepared probe Hcy-SA in NIRF / PA dual-modality imaging of sulfatase at the cellular level:
[0082] (1) Evaluation of the cytotoxicity of the prepared probe Hcy-SA
[0083] The cytotoxicity of the probe Hcy-SA to living cells was evaluated by the standard methylthiazolyl tetrazolium (MTT) method. MCF-7 cells, HeLa cells, and HEK-293T cells were cultured at 5 × 10 3 All cells were first cultured at 37°C for 24 hours. Then different concentrations of probe Hcy-SA (0, 5, 10, 20, 50, 100 μM) were added and incubated for another 24 hours. After that, the cells were washed with 1× PBS (200 μL). Then, methylthiazolyl tetrazolium reagent (MTT, 10 μL, 5 mg / mL) was added and incubated at 37°C for 4 hours. Dimethyl sulfoxide (100 μL / well) was then added for 10 minutes to dissolve the purple crystal precipitate. The absorbance at 490 nm was obtained on the ELx800™ microplate reader, and the results are shown in Figure 2. Fig.11 shown.
[0084] Depend on Fig.11 It can be observed that the survival rates of all cell lines incubated with probe Hcy-SA at concentrations up to 100 μM were over 87%, confirming the low toxicity and good biocompatibility of the prepared probe Hcy-SA in biological applications.
[0085] (2) Investigating the ability of the prepared probe Hcy-SA to image sulfatase in living cells using NIRF / PA dual-modality imaging
[0086] To explore the ability of probe Hcy-SA for NIRF / PA dual-modality imaging of sulfatase in living cells, MCF-7 cells that can highly express sulfatase were placed in a confocal culture dish and cultured for 24 hours. The cells were incubated with 1 mL of fresh culture medium containing probe Hcy-SA (50 μM) at 37°C for 3 hours. For the control group, the cells were incubated with 1 mL of fresh culture medium for 3 hours. In the inhibition experiment, the cells were pre-incubated with sulfatase inhibitor STX-64 (10 μM) at 37°C for 6 hours and then incubated with Hcy-SA (50 μM) for 3 hours. The cells were washed three times with cold PBS before imaging. For cell NIRF imaging, the excitation wavelength was 640 nm, and the fluorescence signal of probe Hcy-SA was collected in the range of 690nm~780nm. The results are shown in Figure 12. For cell PA imaging, before imaging, the cells of each group were digested with trypsin, centrifuged and redissolved in fresh culture medium, and transferred to 1.5 mL centrifuge tubes and subjected to PA imaging using the MSOT imaging system. Scanning from 680nm to 850nm at 10nm intervals, the results are as follows Fig.12 As shown in B.
[0087] from Fig.12A As can be seen, after MCF-7 cells were incubated with the probe Hcy-SA, they showed a strong NIRF signal, which may be attributed to the specific activation of the probe Hcy-SA by intracellular sulfatase. In contrast, cells pretreated with the sulfatase inhibitor STX-64 and then incubated with the probe Hcy-SA showed relatively weak NIRF intensity. These results indicate that the activated NIRF signal does come from the specific catalytic hydrolysis of the probe Hcy-SA by intracellular sulfatase.
[0088] We also investigated the ability of the probe Hcy-SA to image sulfatase activity in living cells using PA. Fig.12 As shown in B, the PA signal of MCF-7 cells treated with probe Hcy-SA was much stronger than that of the control group and the group pretreated with STX-64, confirming that probe Hcy-SA can produce obvious PA response to sulfatase in cells, and also proved the feasibility of probe Hcy-SA for PA imaging of intracellular sulfatase activity. In short, all these results prove that the prepared probe Hcy-SA has the potential for NIRF / PA dual-modality imaging of sulfatase activity in living cells.
[0089] (3) Investigating the ability of the probe Hcy-SA to detect sulfatase activity in different cells by flow cytometry
[0090] In order to compare the sulfatase activity in different cells, we used flow cytometry to study the strength of NIRF signals in different cells treated with the probe Hcy-SA. Considering that the sulfatase levels of some cancer cells are significantly higher than those of normal cells, we selected MCF-7 cells and HeLa cells as positive cell models and HEK-293T cells as negative cell models. First, MCF-7 cells, HeLa cells, and HEK-293T cells were cultured with 50 μM Hcy-SA at 37°C for 3 hours. After washing the cells three times with cold PBS, the cells were digested with trypsin and transferred to centrifuge tubes for flow cytometric analysis. The excitation wavelength was 638 nm, and the fluorescence signal acquisition range was 690 nm~780 nm. The results are shown in Fig.13 shown.
[0091] Depend on Fig.13 It can be seen that the intensity of NIRF activated in MCF-7 cells and HeLa cells is much stronger than that in HEK-293T cells. This is because MCF-7 cells and HeLa cells express higher levels of sulfatase, which activates more probes Hcy-SA and produces more fluorophores. This result also proves that the probe Hcy-SA can distinguish tumor cells from normal cells based on the size of sulfatase activity, which provides a powerful tool for the diagnosis of sulfatase-related cancers.
[0092] (4) Investigating the localization ability of the probe Hcy-SA for imaging sulfatase activity in subcellular organelles
[0093] In order to study the feasibility of using the probe for the detection of sulfatase activity in subcellular organelles, subcellular organelle co-localization experiments were performed using cell fluorescence confocal imaging technology. MCF-7 cells were first incubated with 50 μM of the probe Hcy-SA in 1 mL of fresh culture medium at 37°C for 3 hours. Then, mitochondrial localization reagent (Mito-Tracker green, 100 nM) or lysosomal localization reagent (Lyso-Tracker green, 100 nM) was added and incubated for another 30 min. For NIRF imaging of the probe Hcy-SA, the excitation wavelength was 640 nm and the fluorescence signal collection range was 690nm~780nm. In order to obtain the fluorescence signals of the mitochondrial localization reagent and the lysosomal localization reagent, the fluorescence signal of 500-540 nm was collected under 488 nm excitation, and the results are shown in Figure 2. Fig.14 .
[0094] Fig.14 The results showed that the activated fluorescence signal in the cells colocalized well with the lysosomal localization reagent, with a high Pearson correlation coefficient (PCC) of 0.93. However, the activated NIRF signal colocalized poorly with the mitochondrial localization reagent, with a PCC of only 0.21. The above results indicate that the prepared probe Hcy-SA can specifically monitor the activity of sulfatase in lysosomes.
[0095] Example 5 Investigating the ability of the prepared probe Hcy-SA to perform NIRF / PA dual-modality imaging of sulfatase at the in vivo level
[0096] (1) Investigating the potential of the probe Hcy-SA for NIRF / PA imaging of sulfatase in living tumors
[0097] First, a tumor mouse model was constructed. All animal experiments were performed in accordance with the guidelines issued by the Ethics Committee of Qufu Normal University (approval number: QF2022-023L). Female BALB / c nude mice (4 weeks old, 18-22 g) were used for the animal tumor model. Since sulfatase is highly expressed in MCF-7 cells, a subcutaneous MCF-7 tumor-bearing mouse model was established to verify the feasibility of the probe Hcy-SA for in vivo sulfatase NIRF / PA dual-mode imaging. 1×10 7 A suspension of MCF-7 cells was implanted into the right hip joint of each mouse.
[0098] The pretreatment of in vivo NIRF and PA imaging was performed according to the same steps as below. First, nude mice bearing MCF-7 tumors were divided into three groups and pretreated with different conditions. Each group included 5 mice. The first group was injected with sterile PBS (50 μL) into the mouse tumor tissue and incubated for 4 h as the control group. The second group was injected with Hcy-SA probe (200 μM, 50 μL) into the mouse tumor tissue and incubated for 4 h as the sample group. The third group was pre-injected with sulfatase inhibitor STX-64 (at 200 μM, 100 μL) into the mouse tumor tissue for 6 h, and then injected with Hcy SA probe (200 μM, 50 μL) into the mouse tumor tissue for incubation for 4 h as the inhibition group. In addition, in vivo NIRF and PA images were collected before injection (0 h) and at different time points (0.5, 1, 2, 4, 10 h) after intratumoral injection of Hcy-SA probe (200 μM, 50 μL). Prior to PA / NIRF imaging, all mice were anesthetized with 1% isoflurane in oxygen. For in vivo NIRF imaging, all fluorescent images of mice were captured on an IVIS Lumina XR small animal imaging system (Caliper, Switzerland) with a Cy5.5 filter (690–760 nm). Anesthetized mice were placed in the imaging chamber and the tumor site was placed in the field of view. All imaging parameters were kept constant throughout the experiment. Data were analyzed using Living Image 4.0 software. ROIs of equal area in the tumor region were obtained for further analysis. For in vivo PA imaging, all PA images of mice were captured on a multispectral photoacoustic tomography (MSOT) imaging system (inVision256 TF, iTheraMedical GmbH). Each mouse was fixed with a double leg slide and placed in a 32°C water bath with excitation wavelengths from 680 nm to 850 nm at 10 nm intervals. The entire tumor was scanned with each wavelength at 0.3 mm intervals. Directed ICA hybrid spectral decomposition was introduced to separate the signal from the activated probe and the signal from light absorbers in the tissue (e.g., hemoglobin). The average PA intensity was obtained from five different ROIs of the tumor using ViewMSOT.
[0099] from Fig.15 As can be seen from A and 15 B, after the probe Hcy-SA was injected into the tumor, the NIRF intensity of the tumor area gradually increased over time and reached the maximum intensity at 4 hours, indicating that the probe Hcy-SA produced a near-infrared fluorescence response to the sulfatase in the tumor area in vivo. Fig.15As shown in Figures C and D, the NIRF signal in the tumor area of mice in the Hcy-SA sample group was enhanced by 7.2 times compared with the control group, confirming that the probe Hcy-SA was used to achieve high-contrast NIRF imaging of sulfatase in living tumors. In addition, the NIRF signal in the sulfatase inhibitor STX-64 inhibition group was significantly weakened. This result further confirmed that the enhancement of NIRF signals in MCF-7 tumors was attributed to the specific response of Hcy-SA to sulfatase in living tumors.
[0100] In addition, the probe Hcy-SA was also used for PA imaging of sulfatase activity in tumor areas of tumor-bearing mice. Fig.16 As shown in A and 16 B, the PA signal in the mouse tumor area gradually increased with time and reached a peak about 4 hours after the injection of the probe Hcy-SA. This indicates that the probe produced a photoacoustic response to the sulfatase in the living tumor area. Fig.16 As shown in Figures C and D, the control group injected with PBS or the inhibition group injected with the sulfatase inhibitor STX-64 did not show significant PA signal enhancement in the tumor area, indicating that the activated PA signal indeed originated from the specific response of Hcy-SA to sulfatase in the tumor area. In addition, the PA signal in the tumor area of tumor-bearing mice injected with the probe Hcy-SA was 5.5 times that of the control group, confirming that Hcy-SA has great potential in high-contrast PA imaging of sulfatase in tumor tissue ( Fig.16 D). In conclusion, the above results indicate that the probe Hcy-SA can be used for high-specificity and high-contrast NIRF / PA dual-modality imaging of sulfatase in living tumors, and also show that it has the potential to diagnose sulfatase-related tumors in vivo.
[0101] (2) Study on the metabolic pathway of the probe Hcy-SA in vivo
[0102] To investigate the in vivo metabolic pathways, the probe Hcy-SA was injected into live tumor-bearing mice. After 20 hours, the mice were killed, and the tumors, liver, spleen, kidneys, lungs, hearts, and brains were collected for in vivo NIRF imaging analysis. The metabolism of Hcy-SA in mice was performed using an IVIS animal imaging system. Specifically, Hcy-SA (200 μM, 50 μL) was injected into mice bearing MCF-7 tumors, and the mice were euthanized 12 hours later. Major organs such as the heart, liver, spleen, lungs, and kidneys as well as tumors were carefully collected and placed on a culture dish after washing with saline. MCF-7 tumor-bearing mice injected with PBS were used as controls. Fluorescence images of mice were captured using a Cy5.5 filter (690-760 nm) on an IVIS Lumina XR small animal imaging system (Caliper, Switzerland). The fluorescence intensity of each organ and tumor was analyzed using Living Image 4.0 software. The results are shown in Figure 2. Fig.17 shown.
[0103] Fig.17 A and 17 B show that NIRF signals mainly appear in the liver and tumors, indicating that the reaction products of Hcy-SA to sulfatase are mainly metabolized and cleared in the liver.
[0104] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable ordinary technicians in the field to understand the content of the present invention and implement it accordingly, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made based on the essence of the content of the present invention should be included in the protection scope of the present invention.
Claims
1. An activated near-infrared fluorescence / photoacoustic dual-mode in vivo imaging probe for detecting sulfatase, It is characterized in that The dual-mode in vivo imaging probe is named Hcy-SA, and its chemical structure is shown in Formula I: Formula Ⅰ.
2. Use of the dual-mode in vivo imaging probe according to claim 1 in preparing a probe for localizing to lysosomes.
3. A method for preparing the dual-mode in vivo imaging probe according to claim 1, It is characterized in that The following steps are involved: Pyridine sulfur trioxide, hemicyanine dye Hcy-OH, sodium ethoxide and N,N-dimethylformamide are mixed and stirred for reaction; vacuum concentration is performed, and dichloromethane, methanol and acetic acid are used as eluents to purify the obtained residue by column chromatography to obtain a blue-green solid product named Hcy-SA; the chemical structure of the hemicyanine dye Hcy-OH is shown in Formula II: Formula II.
4. The preparation method according to claim 3, It is characterized in that The preparation method of the hemicyanine-like dye Hcy-OH is as follows: triethylamine is slowly added to a DMF solution of 4-chlororesorcinol and stirred; then the compound CySO is added 3 Cl in DMF solution, stirred; after purification, Hcy-OH was obtained; the compound CySO 3 The structural formula of Cl is shown below: 。 5. The preparation method according to claim 3, It is characterized in that The stirring reaction time is more than 12 h; the temperature is 50 °C.
6. The preparation method according to claim 3, It is characterized in that The eluent was dichloromethane, methanol, and acetic acid in a volume ratio of 8:1:0.1.
